GENB (Generate Biomedicines) EV-to-FCF: (As of Jun. 29, 2026)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Generate Biomedicines's Enterprise Value is $1,709.43 Mil. Generate Biomedicines does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Generate Biomedicines's EV-to-FCF at this moment.

The historical rank and industry rank for Generate Biomedicines's EV-to-FCF or its related term are showing as below:

GENB' s EV-to-FCF Range Over the Past 10 Years
Min: -8.98   Med: 0   Max: 0
Current: -8.37
GENB's EV-to-FCF is ranked worse than
100% of 336 companies
in the Biotechnology industry
Industry Median: 14.885 vs GENB: -8.37

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-06-29), Generate Biomedicines's stock price is $16.92. Generate Biomedicines does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Generate Biomedicines's PE Ratio (TTM) at this moment.

Generate Biomedicines  (NAS:GENB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Generate Biomedicines's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.92/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Generate Biomedicines EV-to-FCF Related Terms

Generate Biomedicines EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines EV-to-FCF Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
EV-to-FCF
0.00 0.00

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
EV-to-FCF 0.00 0.00

GENB vs PVLA, SLBT, NKTR: EV-to-FCF Comparison

For the Biotechnology subindustry, Generate Biomedicines's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Generate Biomedicines EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Generate Biomedicines's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Generate Biomedicines's EV-to-FCF falls into.


GENB
6GF Score
Generate Biomedicines Inc GENB
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines EV-to-FCF Calculation

Generate Biomedicines's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1709.433/
=

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price